March 13th at 1:00PM MST
Neural Mechanisms of Risk for Problem-Level Cannabis Use Among Emerging Adults
Dr. Lichenstein is a licensed clinical psychologist, an Assistant Professor of Psychiatry, and Assistant Director of the Yale Imaging and Psychopharmacology (YIP) Lab at Yale School of Medicine. She received her BA in Psychology from Bard College (2008), and her […]
February 13th at 1:00PM MST CANCELLED
Cannabinoid Receptor 1 in Lungs: Driving under the influence of endocannabinoids and cannabinoids towards inflammatory lung diseases
Dr Resat Cinar is a principal investigator and the chief of Section on Fibrotic Disorders at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) since January 2021 […]
January 9th at 1:00PM MST
Dr. Kevin Boehnke is an Assistant Professor in the Department of Anesthesiology and the Chronic Pain and Fatigue Research Center. Kevin received his doctorate from the University of Michigan School of Public Health in Environmental Health Sciences in 2017. He is also a yoga instructor. His current research focuses on therapeutic applications […]
December 12th at 1:00PM MST
Cannabis-related psychiatric disorders
Dr. David Gorelick earned his bachelor degree in psychology from Cornell University and his medical degree and PhD in pharmacology from Albert Einstein College of Medicine. After completing his psychiatry residency at UCLA, he remained on the faculty until 1989, when he moved to the NIDA Intramural Research […]
10 October 2024, 1:00PM MST
Cannabis and driving: knowns and known unknowns
Dr. Pearlson’s medical training was at the University of Newcastle upon Tyne in England. Following internship he completed a graduate degree in philosophy at Columbia University in New York and was then successively a resident, postdoctoral fellow and faculty member at Johns Hopkins […]
12 September 2024, 1:00PM MST
Chronic and Acute Effects of High Potency Cannabis Flower and Concentrates on Cognition
Dr. Carrie Cuttler received her Ph.D. in Psychology at the University of British Columbia (UBC) and subsequently conducted a post-doctoral fellowship in the Department of Psychiatry at UBC. She is currently an Associate Professor and Director of […]
Interactions of Delta-9 Tetrahydrocannabinol
July 11, 2024, 1:00 PM
Dr. Weerts is a Professor in the Department of Psychiatry and Behavioral Sciences at the Johns Hopkins University School of Medicine, and core faculty in the preclinical Division of Behavioral Biology (DBB) the Behavioral Pharmacology Research Unit (BPRU) for human clinical and laboratory research. She has […]
Limonene, THC, Herbal Synergy and the Entourage Effect
June 13, 2024, 1:00PM MT
Ethan Russo, MD, is a board-certified child and adult neurologist(1987), psychopharmacologist, and Founder/CEO of CReDO Science. He is also Chief Medical Officer to Andira Pharmaceuticals, Senior Medical Advisor to Canurta, and Medical Director of Breeder’s Best. He was Director of R&D for the […]
How the CB1 cannabinoid receptor communicates within the cell via associated proteins
April 11, 2024, 1 PM MST
Dr. Allyn C. Howlett is a Professor of Physiology and Pharmacology at Wake Forest University School of Medicine, Assistant Dean of WFU Graduate School Biomedical Programs, and Director of the Office of Postdoctoral Education. Dr. Howlett is an […]
From Seed to Synapse: Modeling the Long-Term
Impacts of Developmental Cannabis Exposure
March 14, 2024, 1 PM MST
Dr. Ryan McLaughlin is an Associate Professor in the Department of Integrative Physiology and Neuroscience at Washington State University (WSU). The overarching goal of Dr. McLaughlin’s research program is to determine how endogenous and exogenous cannabinoids affect the brain […]
The therapeutic promise of non-addicting cannabinoid analgesics
February 2024
Andrea G. Hohmann is a Linda and Jack Gill Chair of Biomolecular Science and Professor of Psychological and Brain Sciences at Indiana University Bloomington. Dr. Hohmann received her Ph.D. from Brown University and completed postdoctoral training at NIMH and NIDCR in functional neuroanatomy and pain and neurosensory […]
Preclinical Assessment of Cannabinoid-Based Medications for Treatment of Multidimensional Opiod Withdrawal
January 2024
Cassie Moore, PhD is an Assistant Professor in the Division of Behavioral Biology at the Johns Hopkins University School of Medicine. Her research uses animal models to explore the balance between potential benefits and consequences of cannabinoid-based medications. Recent projects have been focused […]
December 2023
Jane Metrik, Ph.D., is Professor in the Departments of Behavioral and Social Sciences and Psychiatry and Human Behavior at Brown University based at the Center for Alcohol and Addiction Studies. She holds a joint appointment at the Providence VA Medical Center, as a research scientist and as a licensed clinical psychologist. Trained in the Joint […]
November 2023
Dr. Emily Bates is an Associate Professor in the Department of Pediatrics at the University of Colorado School of Medicine. She started her career in research as an undergraduate student at the University of Utah studying developmental signaling in fruit flies. Dr. Bates studied neurodegeneration and ion channel function as a PhD student at […]
October 2023
Tess Eidem earned her Ph.D. in Microbiology discovering novel antimicrobial compounds against bacterial pathogens, and she has continued to expand her knowledge in and outside of the lab, building a strong background in manufacturing, product safety and quality, and microbial detection and prevention measures with a focus on controlled environment agriculture (CEA) settings. Dr. […]
September 2023
Dr. Vandrey is an experimental psychologist with degrees from the University of Delaware (BA) and University of Vermont (PhD). He is currently a Professor at the Behavioral Pharmacology Research Unit (BPRU). Dr. Vandrey’s research focuses primarily on the impact of route of administration, dose, and chemical composition of cannabis products on resultant drug effects […]